Peter Wirth

(Mr. Peter Wirth J.D.)

Currently holds positions in Genzyme Corp and Syros Pharmaceuticals Inc

Positions

Position Company Period
Executive Vice President - Legal and Corporate Development, Secretary Genzyme Corp May 22, 2008 -
Independent Chairman of the Board Syros Pharmaceuticals Inc Jan. 27, 2017 -
Peter Wirth's trades of Zai Lab Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-09 2022-12-08
US Zai Lab Ltd (9688)
S Sale
4,000 -100.0%
35.33
USD 141,320 		4,000 -100.0% 35.33 USD 141,320
2022-12-09 2022-12-08
US Zai Lab Ltd (9688)
S Sale
3,852 -1.1%
35.37
USD 136,245 		3,852 -1.1% 35.37 USD 136,245
2021-12-08 2021-12-08
US Zai Lab Ltd (9688)
B Purchase
4,000 +1.2%
71.36
USD 285,440 		4,000 +1.2% 71.36 USD 285,440
2020-06-24 2020-06-23
S Sale
14,026
0.00
USD 0 		14,026 0.00 USD 0
2020-06-24 2020-06-23
S Sale
10,240
0.00
USD 0 		10,240 0.00 USD 0
2020-06-24 2020-06-23
S Sale
9,847
0.00
USD 0 		9,847 0.00 USD 0
2020-06-24 2020-06-23
S Sale
18,585
0.00
USD 0 		18,585 0.00 USD 0
2020-06-24 2020-06-23
S Sale
25,756
0.00
USD 0 		25,756 0.00 USD 0
2020-06-24 2020-06-23
B Purchase
63,299
0.00
USD 0 		63,299 0.00 USD 0
// ... existing code ... // ... rest of the file ...